SCI时时刷

search
+
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations
It is well known that healthcare resource constraints influence the capacity to deliver care, affecting both the costs and...
Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients’ Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany
Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients’ Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany
To compare the implementation of collaborative dementia care management (cDCM) across two settings regarding patients̵...
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium
Adequate insulin injection technique (IIT) is crucial to optimize the efficacy of diabetes therapy. Widespread non-practic...
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data
This study assessed the cost-effectiveness of nivolumab plus ipilimumab (NIVO+IPI) versus platinum-doublet chemotherapy (c...
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India
This study is an economic evaluation of total knee replacement (TKR) in comparison with non-surgical management in India. ...
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey
In the absence of a vaccination programme, the coronavirus disease 2019 (COVID-19) pandemic had substantial impacts on pop...
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis
Breast cancer (BC) constitutes a significant public health challenge in Italy, with a considerable impact on healthcare re...
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis
We evaluated the cost-effectiveness of a bundled intervention including an antimicrobial stewardship program (ASP), procal...
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review
Haemophilia is a rare genetic bleeding disorder that leads to musculoskeletal complications. The high cost of haemophilia ...
From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment
From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment
The aim of this study was to define the economic and organizational impacts related to a broader utilization of bictegravi...
Digital Versus Paper-Based Consent from the UK NHS Perspective: A Micro-costing Analysis
Digital Versus Paper-Based Consent from the UK NHS Perspective: A Micro-costing Analysis
The paper-based consent pathway can be associated with missing information, error, and inadequate patient comprehension. D...
Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment
Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment
This study evaluated costs associated with adverse events (AEs) in previously untreated real-world patients with advanced ...
Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years
Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years
Evidence on health economic outcomes for percutaneous coronary intervention (PCI) comparing different contemporary drug-el...
Mortality, Clinical Complications, and Healthcare Resource Utilization Associated with Managing Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-occlusive Crises in Italy
Mortality, Clinical Complications, and Healthcare Resource Utilization Associated with Managing Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-occlusive Crises in Italy
To examine the clinical burden and healthcare resource utilization (HCRU) among patients with transfusion-dependent β...
Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing
Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing
Cancer screening plays a critical role in early disease detection and improving outcomes. In Australia, established screen...
Costs of Illness for Huntington’s Disease: A Systematic Review
Costs of Illness for Huntington’s Disease: A Systematic Review
Huntington’s disease (HD) is associated with significant financial burden for patients and payers. The objective was...
Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA
Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA
The FRESCO-2 trial established the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal c...
Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study
Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study
Vedolizumab is a gut‐selective anti‐lymphocyte trafficking biologic indicated for the treatment of adult patie...
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis
Immunoglobulin A nephropathy (IgAN) is a rare progressive disease that can lead to kidney failure. The current study aimed...
Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand
Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand
Heart failure (HF) in type 2 diabetes (T2D) patients poses a significant clinical and financial burden. While sodium-gluco...
Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial
Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial
Shared decision-making (SDM) plays a crucial role in breast cancer care by empowering patients and reducing decision regre...
Healthcare Resource Utilization and Associated Costs During the First 5 Years After Diagnosis and at the End of Life: A Nationwide Cohort Study of Patients with Multiple Myeloma in Finland
Healthcare Resource Utilization and Associated Costs During the First 5 Years After Diagnosis and at the End of Life: A Nationwide Cohort Study of Patients with Multiple Myeloma in Finland
The burden associated with the treatment of patients with multiple myeloma (MM) is expected to increase due to the aging p...
Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment
Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment
Understanding the socioeconomic burden of multiple sclerosis (MS) is essential to inform policymakers and payers. Real-wor...
The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System
The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System
Gastroesophageal reflux disease (GERD) is a common ailment associated with troublesome symptoms. The standard of care in I...
Clinicians’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
Clinicians’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
Four sphingosine-1-phosphate receptor (S1PR) modulators are currently available in the USA for treating relapsing forms of...
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK
Oral corticosteroids (OCS) are effective anti-inflammatory agents used across a range of conditions. However, substantial ...
Economic Impact of Bladder Cancer in the USA
Economic Impact of Bladder Cancer in the USA
Incidence and mortality for bladder cancer has changed very little over the past 20 years. Approximately 40% of patients w...
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
Here we estimate the cost-effectiveness of olaparib in the Spanish National Health Service (SNHS) as adjuvant treatment of...
A Systematic Review of the Impact of Spinal Cord Injury on Costs and Health-Related Quality of Life
A Systematic Review of the Impact of Spinal Cord Injury on Costs and Health-Related Quality of Life
To systematically review the health-related quality of life (HRQoL) burden and costs of spinal cord injury (SCI) on health...
阅读更多
format_indent_increase